0001127602-24-000120.txt : 20240102 0001127602-24-000120.hdr.sgml : 20240102 20240102161350 ACCESSION NUMBER: 0001127602-24-000120 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240101 FILED AS OF DATE: 20240102 DATE AS OF CHANGE: 20240102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FONTEYNE PAUL R. CENTRAL INDEX KEY: 0001727550 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 24502538 MAIL ADDRESS: STREET 1: C/O RESTORBIO, INC. STREET 2: 501 BOYLSTON STREET SUITE 6102 CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-977-5700 MAIL ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-01-01 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001727550 FONTEYNE PAUL R. C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR WALTHAM MA 02451 1 0 Common Stock 2024-01-01 4 A 0 3341 0 A 16438 D Stock Option (Right to Buy) 59.86 2024-01-01 4 A 0 5748 59.86 A 2030-12-31 Common Stock 5748 5748 D This restricted stock unit was granted on January 1, 2024. The restricted stock unit will fully vest on the first anniversary of the date of grant, subject to his continued service as a director, or upon later termination of his service as a director at his election. This option was granted on January 1, 2024. The option vests quarterly on the last day of each quarter from the date of grant, subject to his continued service as a director and expires seven years after the date of grant. /s/ David Watson, attorney-in-fact for Paul Fonteyne 2024-01-02